Under the approval, Aetna must sell off its private Medicare drug plans
WEDNESDAY, Oct. 10, 2018 (HealthDay News) — A $69 billion merger between health insurer Aetna and pharmacy manager CVS Health has been approved, according to the U.S. Justice Department.
Under the approval, Aetna must sell off its private Medicare drug plans, The New York Times reported.
CVS Health was the last of the large independent pharmacy managers to reach a deal with a major insurer. Last month, the Justice Department approved insurer Cigna’s takeover of pharmacy manager Express Scripts, The Times reported. The companies involved in these mergers say they will improve coordination of care for consumers, but critics say consumers could be left with far fewer choices and potentially higher costs.
“This type of consolidation in a market already dominated by a few, powerful players presents the very real possibility of reduced competition that harms consumer choice and quality,” George Slover, senior policy counsel for the advocacy group Consumers Union, said in a statement, The Times reported.
Insurance Poses Barrier to Virtual Pulmonary Rehabilitation for COPD
Many Young Adults Not Prepared to Manage Their Own Health Care
1 in 4 U.S. Workers Sticking With a Job Strictly for Health Insurance
2018 to 2024 Saw Rise in Insurance Denials for Brand-Name Drugs
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors
People With Autism Have Shorter Life Expectancy
Anifrolumab Tied to Lower Hospitalization, Infection Risk in Lupus